Herpes zoster: a possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals.

PubWeight™: 1.22‹?› | Rank: Top 10%

🔗 View Article (PMID 3013955)

Published in J Am Acad Dermatol on June 01, 1986

Authors

A E Friedman-Kien, F L Lafleur, E Gendler, N P Hennessey, R Montagna, S Halbert, P Rubinstein, K Krasinski, E Zang, B Poiesz

Articles citing this

"The end of innocence" revisited: resistance of herpesviruses to antiviral drugs. Clin Microbiol Rev (1994) 1.54

The risk and prognosis of cancer after hospitalisation for herpes zoster: a population-based follow-up study. Br J Cancer (2004) 1.13

Ocular examination and diagnosis in patients with the acquired immunodeficiency syndrome. West J Med (1993) 1.10

Herpes zoster: a clinical study in 205 patients. Indian J Dermatol (2011) 0.89

A case of human immunodeficiency virus infection initially presented with disseminated herpes zoster. Ann Dermatol (2010) 0.88

Herpes zoster and the stage and prognosis of HIV-1 infection. Genitourin Med (1997) 0.85

Four cases of vesicular lesions in adults caused by enterovirus infections. J Clin Microbiol (1988) 0.78

Orocutaneous Manifestations as Markers of Disease Progression in HIV Infection in Indian Setting. Med J Armed Forces India (2011) 0.77

Prevalence of shingles and its association with PTSD among HIV-infected women in Rwanda. BMJ Open (2015) 0.76

Audio-vestibular function in human immunodeficiency virus infected patients in India. Indian J Sex Transm Dis (2012) 0.75

Dermatological manifestations in human immunodeficiency virus infected patients: Morphological spectrum with CD4 correlation. Indian J Sex Transm Dis (2013) 0.75

Early Clinical Signs and Symptoms of HIV Infection: Delaying progression to AIDS. Can Fam Physician (1992) 0.75

Immunoelectron microscopy for rapid diagnosis of varicella-zoster virus in a complicated case of human T-cell lymphotropic virus type 1 infection. J Clin Microbiol (1992) 0.75

Pharmacologic management of herpes zoster and postherpetic neuralgia. Can Fam Physician (1994) 0.75

Articles by these authors

Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet (1987) 13.98

National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 1. Epidemiologic results. Ann Intern Med (1983) 6.67

Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med (1996) 6.49

Doses of nicotine and lung carcinogens delivered to cigarette smokers. J Natl Cancer Inst (2000) 6.01

Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection. J Virol (1987) 5.27

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med (2001) 5.14

Disseminated Kaposi's sarcoma in homosexual men. Ann Intern Med (1982) 4.98

Risk factors for Kaposi's sarcoma in homosexual men. Lancet (1982) 4.70

Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line. Virology (1981) 4.68

Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet (1995) 4.31

Failure of voluntary testing for human immunodeficiency virus to identify infected parturient women in a high-risk population. N Engl J Med (1988) 3.56

HPV-16-related DNA sequences in Kaposi's sarcoma. Lancet (1992) 3.09

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood (2001) 2.99

Enzymatic amplification of HTLV-I viral sequences from peripheral blood mononuclear cells and infected tissues. Blood (1988) 2.98

Results of large scale media antismoking campaign in Australia: North Coast "Quit for Life" programme. Br Med J (Clin Res Ed) (1983) 2.97

Fluorescein angiography complication survey. Ophthalmology (1986) 2.96

Kaposi's sarcoma in HIV-negative homosexual men. Lancet (1990) 2.80

Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med (1997) 2.73

Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group. N Engl J Med (1989) 2.73

Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses. J Virol (1981) 2.72

International system for human gene nomenclature (1979) ISGN (1979). Cytogenet Cell Genet (1979) 2.58

Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol (1997) 2.56

High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet (1985) 2.44

Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci U S A (1992) 2.41

Genotoxicity and carcinogenicity in rats and mice of 2-amino-3,6-dihydro-3-methyl-7H-imidazolo[4,5-f]quinolin-7- one: an intestinal bacterial metabolite of 2-amino-3-methyl-3H-imidazo[4,5-f]quinoline. J Natl Cancer Inst (1994) 2.21

Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community. J Infect Dis (2000) 2.18

HIV-1 messenger RNA in peripheral blood mononuclear cells as an early marker of risk for progression to AIDS. Ann Intern Med (1995) 2.18

The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia. Proc Natl Acad Sci U S A (1988) 2.14

Human genes for three complement components that regulate the activation of C3 are tightly linked. J Exp Med (1985) 2.12

Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine. Antimicrob Agents Chemother (1979) 2.10

Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials. Arch Dermatol (2000) 2.09

In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J Exp Med (1989) 2.01

Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J Infect Dis (1982) 1.98

Allele frequency distribution of two highly polymorphic DNA sequences in three ethnic groups and its application to the determination of paternity. Am J Hum Genet (1986) 1.95

Antigenic analysis of Neisseria gonorrhoeae by crossed immunoelectrophoresis. Infect Immun (1976) 1.93

Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines. J Natl Cancer Inst (1995) 1.92

Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation (1997) 1.91

Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds. Antimicrob Agents Chemother (1974) 1.84

Patient-applied podofilox for treatment of genital warts. Lancet (1989) 1.79

Modulation of N-nitrosomethylurea-induced mammary tumor promotion by dietary fiber and fat. J Natl Cancer Inst (1991) 1.79

Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood (2000) 1.75

Phosphonoacetic acid-resistant herpes simplex virus infection in hairless mice. Antimicrob Agents Chemother (1975) 1.72

Characterization of a sequence of human T cell leukemia virus type I from a patient with chronic progressive myelopathy. J Infect Dis (1988) 1.71

Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery. Circulation (1999) 1.69

High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing. AIDS Res Hum Retroviruses (1990) 1.64

IgG antibodies to HIV-1 in urine of HIV-1 seropositive individuals. Lancet (1988) 1.64

Purification of human B cell growth factor. J Immunol (1985) 1.61

Induction of interferon synthesis by synthetic double-stranded polynucleotides. J Virol (1968) 1.61

Localization of human herpes-like virus type 8 in vascular endothelial cells and perivascular spindle-shaped cells of Kaposi's sarcoma lesions by in situ hybridization. Am J Pathol (1996) 1.60

A new human Duffy blood group specificity defined by a murine monoclonal antibody. Immunogenetics and association with susceptibility to Plasmodium vivax. J Exp Med (1987) 1.58

Change points in the series of T4 counts prior to AIDS. Biometrics (1995) 1.58

Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation. Circulation (1997) 1.57

Suppression of the intracellular growth of Shigella flexneri in cell cultures by interferon preparations and polyinosinic-polycytidylic acid. Infect Immun (1972) 1.54

Immunohistochemical detection of papillomavirus antigens in Kaposi's sarcoma. Lancet (1992) 1.52

Disseminated Kaposi's sarcoma syndrome in young homosexual men. J Am Acad Dermatol (1981) 1.51

Kaposi's sarcoma in homosexual men. A seroepidemiologic case-control study. Ann Intern Med (1984) 1.50

Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice. Infect Immun (1977) 1.49

Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res (1995) 1.48

Expression and mutation of the tumor suppressor gene p53 in AIDS-associated Kaposi's sarcoma. Am J Dermatopathol (1997) 1.48

Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. Proc Natl Acad Sci U S A (1994) 1.48

Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery. J Clin Invest (1997) 1.47

Low serum thiol levels predict shorter times-to-death among HIV-infected injecting drug users. AIDS (1997) 1.42

Comparison of human immunodeficiency virus 1 DNA polymerase chain reaction and qualitative and quantitative RNA polymerase chain reaction in human immunodeficiency virus 1-exposed infants. Pediatr Infect Dis J (1999) 1.42

A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP. J Exp Med (1988) 1.40

Prevalence, clinical significance, and strain specificity of neutralizing antibody to the human immunodeficiency virus. J Infect Dis (1987) 1.38

Patents versus transplants. Nature (1996) 1.38

Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons. J Virol (1996) 1.37

Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusion. Evidence of volunteer blood donor cooperation. Transfusion (1985) 1.36

Early diagnosis of human immunodeficiency virus infection in children less than 6 months of age: comparison of polymerase chain reaction, culture, and plasma antigen capture techniques. J Infect Dis (1992) 1.35

CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro. J Virol (1990) 1.34

The development of virus-free labile blood derivatives--a review. Eur J Epidemiol (1987) 1.33

Genetics of juvenile diabetes mellitus. A recessive gene closely linked to HLA D and with 50 per cent penetrance. N Engl J Med (1977) 1.33

The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma. Evidence for a vascular endothelial cell origin. Am J Pathol (1986) 1.32

9-(1,3-Dihydroxy-2-propoxymethyl)guanine (ganciclovir) in the treatment of cytomegalovirus gastrointestinal disease with the acquired immunodeficiency syndrome. Ann Intern Med (1987) 1.32

Genetics of Type I diabetes mellitus: a single, recessive predisposition gene mapping between HLA-B and GLO. With an appendix on the estimation of selection bias. Am J Hum Genet (1981) 1.30

Epithelioid angiomatosis: a distinct vascular disorder in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Lancet (1987) 1.30

Possible association of mycoplasma and viral respiratory infections with bacterial meningitis. Am J Epidemiol (1987) 1.30

Serology for automated cytotoxicity assays. Contrast fluorescence test. Vox Sang (1974) 1.28

Orofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment. Infect Immun (1978) 1.26

Pneumocystis carinii pneumonia in infants infected with the human immunodeficiency virus with more than 450 CD4 T lymphocytes per cubic millimeter. N Engl J Med (1990) 1.25

Maternal predictors of perinatal human immunodeficiency virus transmission. The New York City Perinatal HIV Transmission Collaborative Study Group. Pediatr Infect Dis J (1994) 1.24

Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant (1994) 1.24

Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts. Proc Natl Acad Sci U S A (1988) 1.23

The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. Blood Cells (1994) 1.22

Soluble factor activation of human B lymphocytes. Nature (1981) 1.22

Efficacy of primary chemoprophylaxis against Pneumocystis carinii pneumonia during the first year of life in infants infected with human immunodeficiency virus type 1. J Pediatr (1994) 1.20

Prevalence of HIV infection in New York call girls. J Acquir Immune Defic Syndr (1988) 1.16

Decay-accelerating factor. Genetic polymorphism and linkage to the RCA (regulator of complement activation) gene cluster in humans. J Exp Med (1987) 1.16

Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest (1989) 1.15

Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group. Pediatrics (1995) 1.15

Inactivation of human immunodeficiency, herpes simplex, and vaccinia viruses by sodium oxychlorosene. Lancet (1987) 1.13

DRw determinants on human T cells primed against allogeneic lymphocytes. Transplant Proc (1978) 1.12

Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1. The New York City Perinatal HIV Transmission Collaborative Study Group. J Infect Dis (1995) 1.11

Latent herpes simplex virus infections in sensory ganglia of mice after topical treatment with adenine arabinoside and adenine arabinoside monophosphate. Antimicrob Agents Chemother (1977) 1.11

Human-immunodeficiency-virus infections in infants negative for anti-HIV by enzyme-linked immunoassay. Lancet (1987) 1.11

Choledochocele and recurrent pancreatitis. Diagnosis and surgical management. Am J Surg (1985) 1.11

Dose response of promotion by butylated hydroxyanisole in chemically initiated tumours of the rat forestomach. Food Chem Toxicol (1994) 1.11